On an investor call Friday, analysts grilled the company over its apparent lack of transparency on the matter.

A 51-year-old man died last month after receiving an experimental treatment from Sarepta, the third death this year tied to ...

Second patient death from liver failure after Sarepta's Elevidys gene therapy triggers FDA investigation. Stock crashes 41% ...

Simple steps can boost patient safety, including repeatedly asking patients for their name and birthdate to make sure you have the right patient at the right place. Monitoring statistics such as ...

The patient, who was being treated with an investigational gene therapy for limb-girdle muscular dystrophy, died of acute ...

Healthcare leaders can employ a range of strategies to ensure that patient safety is not compromised when care teams are ...

Sarepta Therapeutics Inc. said another patient has died from acute liver failure after receiving one of its gene therapies, putting additional pressure on the biotech company after the recent deaths ...

Registered nurses at Ascension Saint Agnes Hospital in Baltimore are preparing to strike for the first time in the form of a ...

Lucian Leape, MD, considered by many to be the father of the patient safety movement, died Monday in Lexington, Massachusetts. He was 94. The cause of death was heart failure, his son James told the ...

Patient safety is a point of emphasis for medical facilities, especially now that reimbursements are increasingly being tied to metrics regarding patient satisfaction and quality of care ...

The National Medical Commission (NMC) has instructed medical colleges to form committees to monitor adverse events related to ...

As I reflected on her comments, I realized that tucked within her criticism was an unspoken compliment: She felt comfortable ...